Drugmakers Lobby Washington to Scale Back Proposed China Investment Bans

By Elaine Chen and Daniel Payne · STAT News · 2026-07-22

STAT News reports that pharmaceutical executives are currently pressuring federal lawmakers to soften proposed legislation that would strictly limit capital flow into Chinese firms. This industry pushback comes as Washington considers more aggressive trade and investment barriers

STAT News reports that pharmaceutical executives are currently pressuring federal lawmakers to soften proposed legislation that would strictly limit capital flow into Chinese firms. This industry pushback comes as Washington considers more aggressive trade and investment barriers